1,4,5,6-Tetrahydro-as-triazines. II. Condensation of ... - ACS Publications

Bacteria use expanded genetic code. The genome of every cell on Earth uses four DNA bases—adenine, thymine, cytosine, and guanine—to encode... BUS...
1 downloads 5 Views 424KB Size
1,4, .,i 6- T ETR 4 I-TYn R o-n ,S-TRTAz IN ES . IT E;

\

\ M

w\ 01

e

% I? v

i?

d

Y 3

*

\ \

c u d

0

I

'I

v

"i ?? - 3

220

washed acidic, aqueous solutio11 was made strongly basic with cold aqueous NaOH arid extracted CHClR . The washed (water) and dried (MgSO4) chloroform solution was evaporated in vacuo, and t,he residue was purified either by distillation or crystallization. Method B is identical with method A except that chloroform is used as the reaction solvent instead of absolute ethanol. Method C.-A mixture of 0.10 mole of orthoester, 0.10 mole of P-aminoethylhydrazirie, and 50 ml of ethyl acetate was refluxed for 20 hr and then distilled in z)acuo. Method D is identical with method C except that CHC13 is used as the reaction solvent, instead of ethyl acetate. Method E is the same as method C except that absolute ethanol is used as t,he reaction solvent instead of ethyl acetate. Method F is the same as method R except t,hat the methyl imiiioester hydrochloride is used instead of the ethyl iminoester hydrochloride.

Method G is the same as method F except that niethaiiol is used as the reaction solvent instead of CHC13. 1,4,5,6-Tetrahydro-as-triazine.-A mixture of 30 g (0.40 mole) of @-aminoethylhydraxiIie and 80 g (0.54 mole) of ethyl orthoformate was heated a t reflux temperature for 24 hr and then distilled, bp 98-100" (0.3 mm), yield 20%. Anal. Calcd for C3H7N3: C, 42.34; H, 8.29; S , 47.37. Found: C, 41.82; H, 8.57; N, 47.27. 1,4,5,6-Tetrahydro-us-triazinemonopicrate was prepared iii ethanol and after recrystallization from water; mp 136-138'. I n a l . Calcd for CgH,,N60i: C, 34.40; H, 3.21; S , 26.75. Found: C, 34.61; 13, 3.47; N, 26.95.

Acknowledgment.-The author5 are grateful to Dr. J. Heescheri of the Chemical Physics Laboratory for recording arid interpreting the nmr spectra.

The Synthesis and Pharmacology of 1311-Labeled l,l0-Bis(trimethylammonium)-5-chloro-6-iodo-5-deceneDihalide and Related Neuromuscular Blocking Agents' OVE A. NEDERGAARD~ AND DERXOT B.TAYLOR Uepurtitient of Pharttiucoloyil, School of Jledicine, and Bruzn Reseatch Institute, Cniucrsity of Culrforniu, Loa .Inyelea, C'ulrforniu R e t e w e t l X a r c h 26, 1966 I k z i s e d Manuserapt ReceaLecl .\?ozembei

$OW$

14, 1966

dihalide has beeii acconiHyut,hesis of IJlI-labeled 1,10-bis(trimethylammoniiini)-3-chloro-6-iodo-.i-decelie plished by several different methods. It is a stable depolarizing iieuromiiscular blocking agelit,. Some related uiisaturated diquateriiary amines of interest iii structure-activity relationships were also prepared.

Stable depolarizing neuromuscular blocking agents such as 1,10-bis(trimethylammonium)decane dihalide [decamethonium (I)] characteristically produce a dual block on isolat'ed nervemuscle preparat'i~ns.~It has been suggested4 that t'he second phase of this biphasic block is related to the penetration of the drug into the skeletal muscle fiber. This hypothesis can be studied most conveniently by using labeled depolarizing drugs. Decamethonium (I) labeled with K-methyl-14C has been ~ r e p a r e d . ~However, labeling wit,h l 3 I I (14CH3)3N+(CHa)ioS+( "CH3)s

I

would be advantageous, sirice y-emitting isotopes permit easier and more accurate counting t'han is possible with p emitters. Furt'hermore, the counting is siniplified since no disintegration of the tissue or extractioii (1) (a) This work was supported in part by U. S. Public Health Service Grant B - i 3 8 ( C i ) . (b) Some of the results contained in the present report have been submitted by one of us (0.A . N.) in partial fulfillment of t h e requirements for the degree of XI.Yc. in Pharmacology, University of California a t Los Aneeles. 1961. (0) Presented in part a t the American Pharmacological Society Meeting, Nashville, Tenn.. :lug 1962. (d) D. B. Taylor and 0. .$. Nedergaard, Pharmacologist, 4 , 183 (1962). ( 2 ) Investigation carried o u t during t h e tenure of U. S. Public Health Service Predoctoral Fellowship. (3) (a) D. J. Jenden. I